LifeNome Inc. – Trademark Portfolio
Entity Type: 03
LifeNome Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include 9MOONS, LIFENOME, GENOMICS AI, PRECISION CONSUMPTION, and PRECISION CONSUMPTION AI. The owner is based in New York, NY.
1441 Broadway Suite 3112
New York, NY 10018
Showing of trademarks Trademarks
Trademark Classifications
LifeNome Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does LifeNome Inc. have?
LifeNome Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned, 2 cancelled.
What trademark classes does LifeNome Inc. file in?
LifeNome Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LifeNome Inc.'s most well-known trademarks?
LifeNome Inc.'s registered trademark portfolio includes well-known marks such as 9MOONS, LIFENOME, GENOMICS AI, PRECISION CONSUMPTION, and PRECISION CONSUMPTION AI. These are among 6 currently registered trademarks in the portfolio.
What is LifeNome Inc.'s trademark registration success rate?
LifeNome Inc. has a 55% trademark registration rate, with 6 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.